SINTX Technologies Inc SINT
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $1.57
- Day Range
- $1.55–1.59
- 52-Week Range
- $1.55–6.76
- Bid/Ask
- $0.00 / $0.00
- Shares Outstanding
- 6.36M
- Market Cap
- $9.79M
- Volume/Avg
- 29,816 / 50,826
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 7.09
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- 38.58%
Company Profile
SINTX Technologies Inc is an advance ceramics company that develops, manufactures, and commercializes silicon nitride biomaterials, composites, devices, and related technologies for medical and other high-value applications. It provides biomedical solutions for medical devices specializing in silicon nitride (Si3N4) for musculoskeletal and antipathogenic applications. It also manufactures silicon nitride parts for customers in the electrical, aerospace, and other industrial sectors. The company is a globalised leader in the research, development, and manufacturing of silicon nitride, and its products have been implanted in humans. The Company operates as one operating segment.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 32
- Website
- https://www.sintx.com
Valuation
|
Metric
|
SINT
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 7.15 |
Price/Sales | 7.09 |
Price/Cash Flow | — |
Price/Earnings
SINT
Financial Strength
|
Metric
|
SINT
|
|---|---|
Quick Ratio | 0.54 |
Current Ratio | 1.04 |
Interest Coverage | −215.65 |
Quick Ratio
SINT
Profitability
|
Metric
|
SINT
|
|---|---|
Return on Assets (Normalized) | −91.40% |
Return on Equity (Normalized) | −250.74% |
Return on Invested Capital (Normalized) | −130.13% |
Return on Assets
SINT
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| LOCK|@gjHP<> | LOCK|!rfN$ | $155B | |||
| Stryker Corp
SYK
| LOCK|ZxXS^>x | LOCK|W& | $121B | |||
| Medtronic PLC
MDT
| LOCK|#!fmh@ | LOCK|zM%@# | $103B | |||
| Boston Scientific Corp
BSX
| LOCK|#@&S@@b | LOCK|>gdl | $64B | |||
| Edwards Lifesciences Corp
EW
| LOCK|n&>Mlc> | LOCK|&cwz | $50B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|^rDpWT | LOCK|G@ | $29B | |||
| DexCom Inc
DXCM
| LOCK|<x@><VG^ | LOCK|M#GkC | $28B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|%?G | LOCK|>b | $26B | |||
| Steris PLC
STE
| LOCK|jqq@TJ | LOCK|Gr%^ | $21B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|l<J!&VQ^ | LOCK|DC | $17B |
United States